EU Rejects Calls To Extend Clinical Trial Regulation Transition Period

Sponsors Worried About Member State Preparedness Are Reminded About Tacit Approval

A senior European Commission official has a clear answer for those expecting the mandatory phase of the EU Clinical Trial Regulation to be delayed. There is no such plan on the cards.

 Young businessman working on a virtual screen of the future and sees the inscription: Clinical trial
Ensuring Operational Stability Of CTIS Is Key Priority for EMA • Source: Alamy

More from Clinical Trials

More from R&D